Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)
Kevin R. Bainey(Alberta Hospital Edmonton), Shamir R. Mehta(Population Health Research Institute), John A. Cairns, Jaydeep Sarma(Wythenshawe Hospital), Jean‐François Tanguay(University of Ottawa), Roxana Mehran(Mount Sinai Hospital), Sunil V. Rao(New York University), Warren J. Cantor(University of Toronto), Robert F. Storey(University of Sheffield), Goran Stanković(University of Belgrade), Thenmozhi Mani(Population Health Research Institute), James L. Velianou(Hamilton General Hospital), Shahar Lavi(London Health Sciences Centre), Gianluca Campo(Azienda Unità Sanitaria Locale di Ferrara), David Wood(Valve (United States)), Mina Madan(Sunnybrook Health Science Centre), Natalia Pinilla‐Echeverri(Population Health Research Institute), Matthias Bossard(University of Lucerne), Robert C. Welsh(University of Alberta), Tej Sheth(McMaster University), Philippe Gabríel Steg(Mount Sinai Hospital)
Cited by 12
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k